| Literature DB >> 30130361 |
Stephen J Gainey1, Gavin P Horn2, Albert E Towers3, Maci L Oelschlager4, Vincent L Tir4, Jenny Drnevich5, Kenneth W Fent6, Stephen Kerber7, Denise L Smith2,8, Gregory G Freund1,3,4.
Abstract
Firefighting activities appear to increase the risk of acute and chronic lung disease, including malignancy. While self-contained breathing apparatuses (SCBA) mitigate exposures to inhalable asphyxiates and carcinogens, firefighters frequently remove SCBA during overhaul when the firegrounds appear clear of visible smoke. Using a mouse model of overhaul without airway protection, the impact of fireground environment exposure on lung gene expression was assessed to identify transcripts potentially critical to firefighter-related chronic pulmonary illnesses. Lung tissue was collected 2 hrs post-overhaul and evaluated via whole genome transcriptomics by RNA-seq. Although gas metering showed that the fireground overhaul levels of carbon monoxide (CO), carbon dioxide (CO2), hydrogen cyanine (HCN), hydrogen sulfide (H2S) and oxygen (O2) were within NIOSH ceiling recommendations, 3852 lung genes were differentially expressed when mice exposed to overhaul were compared to mice on the fireground but outside the overhaul environment. Importantly, overhaul exposure was associated with an up/down-regulation of 86 genes with a fold change of 1.5 or greater (p<0.5) including the immunomodulatory-linked genes S100a8 and Tnfsf9 (downregulation) and the cancer-linked genes, Capn11 and Rorc (upregulation). Taken together these findings indicate that, without respiratory protection, exposure to the fireground overhaul environment is associated with transcriptional changes impacting proteins potentially related to inflammation-associated lung disease and cancer.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30130361 PMCID: PMC6103500 DOI: 10.1371/journal.pone.0201830
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Environmental measurements for OH group mice during overhaul respective of mouse cohort/fire.
| Fire 1 | Fire 2 | Fire 3 | ||
|---|---|---|---|---|
| 18 | 15 | 15 | ||
| Average | 33.9 | 28.3 | 32.8 | |
| Peak | 40.6 | 30.6 | 40.0 | |
| Average | 26 | 28 | 37 | |
| Peak | 70 | 98 | 91 | |
| Average | 0.02 | 0.02 | 0.01 | |
| Peak | 0.08 | 0.05 | 0.05 | |
| Average | 0.1 | 0.6 | 0.4 | |
| Peak | 1.1 | 2.8 | 1.7 | |
| Average | 0.0 | 0.1 | 0.5 | |
| Peak | 2.2 | 1.0 | 2.7 | |
| Average | 20.8 | 20.9 | 20.8 | |
| Minimum | 20.6 | 20.8 | 20.5 | |
CO—NIOSH TWA 35ppm; OSHA TWA 50ppm; NIOSH C 200 ppm; IDLH 1200ppm
CO2—NIOSH TWA 0.5%; OSHA TWA 0.5%; NIOSH ST 3%; IDLH 4%
HCN—NIOSH ST 4.7 ppm OHSA TWA 10 ppm, IDLH 50 ppm
H2S—NIOSH C 10 ppm, OSHA C 20 ppm; IDLH 100 ppm
O2—typically alarm levels are set at <19.5%
Number of different gene entities in NCBI Mus musculus GRCm38.p3 gene annotations.
| Entity Type | Number in Genome | Number After Filtering |
|---|---|---|
| mRNA | 21,198 | 13,743 |
| ncRNA | 12,285 | 1,342 |
| Exon | 4,008 | 144 |
| Misc_RNA | 1,988 | 940 |
| Precursor_RNA | 1,187 | 17 |
| V_segment | 535 | 49 |
| tRNA | 413 | 9 |
| J_segment | 94 | 1 |
| rRNA | 35 | 2 |
| D_segment | 23 | 0 |
| C_region | 20 | 13 |
| Total | 41,786 | 16,261 |
Fig 1Principal component analysis of control, fireground, and overhaul gene expression data following surrogate variables removal.
Principal components 1 and 2 are shown with control samples are represented by circles (red color). The fireground samples are represented by squares (lime color) and the overhaul samples represented as diamonds (blue color). The numeric labels 1, 2, and 3 indicate the cohort.
Number of genes significantly up- or down- regulated (FDR p-value < 0.05) by overhaul (OH) exposure compared with fireground (FG).
| Treatment | Up | Down | Total |
|---|---|---|---|
| FG vs OH | 1,890 | 1,962 | 3,852 |
| FG.1 vs OH.1 | 1,651 | 1,809 | 3,460 |
| FG.2 vs OH.2 | 557 | 687 | 1,244 |
| FG.3 vs OH.3 | 356 | 342 | 698 |
Direction of significantly expressed genes refers to expression level in OH compared to FG as the baseline.
List of significant differentially expressed genes for FG vs OH.
| Gene Symbol | Entrez ID | Gene Name | Fold Change |
|---|---|---|---|
| Igha | 238447 | immunoglobulin heavy constant alpha | 4.24 |
| Igkv5-43 | 381783 | immunoglobulin kappa chain variable 5–43 | 2.89 |
| Ighv1-26 | 629884 | immunoglobulin heavy variable 1–26 | 2.68 |
| Capn11 | 268958 | calpain 11 | 2.54 |
| Ighg2b | 16016 | immunoglobulin heavy constant gamma 2B | 2.53 |
| Rorc | 19885 | RAR-related orphan receptor gamma | 2.48 |
| Gzmk | 14945 | granzyme K | 2.34 |
| Igj | 16069 | immunoglobulin joining chain | 2.32 |
| Ighg1 | 16017 | immunoglobulin heavy constant gamma 1 (G1m marker) | 2.09 |
| Dnase2b | 56629 | deoxyribonuclease II beta | 2.08 |
| Rasd1 | 19416 | RAS, dexamethasone-induced 1 | 1.99 |
| Akr1c14 | 105387 | aldo-keto reductase family 1, member C14 | 1.93 |
| Igkv1-135 | 243420 | immunoglobulin kappa variable 1–135 | 1.85 |
| Cry1 | 12952 | cryptochrome 1 (photolyase-like) | 1.83 |
| Gpr137c | 70713 | G protein-coupled receptor 137C | 1.82 |
| Igkv2-109 | 628268 | immunoglobulin kappa variable 2–109 | 1.75 |
| Gm11827 | 100503518 | predicted gene 11827 | 1.75 |
| Ighv3-6 | 780829 | immunoglobulin heavy variable 3–6 | 1.75 |
| Ctla4 | 12477 | cytotoxic T-lymphocyte-associated protein 4 | 1.73 |
| Doc2b | 13447 | double C2, beta | 1.73 |
| Ddit4 | 74747 | DNA-damage-inducible transcript 4 | 1.73 |
| Ces1g | 12623 | carboxylesterase 1G | 1.72 |
| Nav3 | 260315 | neuron navigator 3 | 1.71 |
| Ighg2c | 404711 | immunoglobulin heavy constant gamma 2C | 1.69 |
| Rasl10b | 276952 | RAS-like, family 10, member B | 1.68 |
| Ryr3 | 20192 | ryanodine receptor 3 | 1.67 |
| Gkn3 | 68888 | gastrokine 3 | 1.66 |
| Lonrf3 | 74365 | LON peptidase N-terminal domain and ring finger 3 | 1.64 |
| Csrnp1 | 215418 | cysteine-serine-rich nuclear protein 1 | 1.63 |
| Gzmb | 14939 | granzyme B | 1.62 |
| Tmem252 | 226040 | transmembrane protein 252 | 1.61 |
| Serpini1 | 20713 | serine (or cysteine) peptidase inhibitor, clade I, member 1 | 1.59 |
| Ighv9-3 | 780825 | immunoglobulin heavy variable V9-3 | 1.58 |
| Scn2b | 72821 | sodium channel, voltage-gated, type II, beta | 1.58 |
| Sox8 | 20681 | SRY (sex determining region Y)-box 8 | 1.57 |
| Gadd45g | 23882 | growth arrest and DNA-damage-inducible 45 gamma | 1.56 |
| BB123696 | 105404 | expressed sequence BB123696 | 1.55 |
| Adm | 11535 | adrenomedullin | 1.54 |
| Gal3st3 | 545276 | galactose-3-O-sulfotransferase 3 | 1.53 |
| Ajap1 | 230959 | adherens junction associated protein 1 | 1.52 |
| Abhd12b | 100504285 | abhydrolase domain containing 12B | 1.52 |
| Kcnip3 | 56461 | Kv channel interacting protein 3, calsenilin | 1.51 |
| Cebpd | 12609 | CCAAT/enhancer binding protein (C/EBP), delta | 1.50 |
| Ly6c2 | 100041546 | lymphocyte antigen 6 complex, locus C2 | -1.51 |
| Col5a3 | 53867 | collagen, type V, alpha 3 | -1.51 |
| Slc22a3 | 20519 | solute carrier family 22 (organic cation transporter), member 3 | -1.51 |
| Muc5b | 74180 | mucin 5, subtype B, tracheobronchial | -1.52 |
| Mnd1 | 76915 | meiotic nuclear divisions 1 | -1.53 |
| Tnfrsf13c | 72049 | tumor necrosis factor receptor superfamily, member 13c | -1.54 |
| Artn | 11876 | artemin | -1.54 |
| Ccno | 218630 | cyclin O | -1.55 |
| Fbp2 | 14120 | fructose bisphosphatase 2 | -1.55 |
| Olfm2 | 244723 | olfactomedin 2 | -1.55 |
| Sp5 | 64406 | trans-acting transcription factor 5 | -1.56 |
| Tnc | 21923 | tenascin C | -1.56 |
| Loxl1 | 16949 | lysyl oxidase-like 1 | -1.56 |
| Elovl1 | 54325 | elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 1 | -1.56 |
| AI854703 | 243373 | expressed sequence AI854703 | -1.56 |
| Retnla | 57262 | resistin like alpha | -1.56 |
| Muc20 | 224116 | mucin 20 | -1.56 |
| Cftr | 12638 | cystic fibrosis transmembrane conductance regulator | -1.57 |
| Tubb4a | 22153 | tubulin, beta 4A class IVA | -1.58 |
| Clmp | 71566 | CXADR-like membrane protein | -1.58 |
| Ccna1 | 12427 | cyclin A1 | -1.58 |
| Mfsd4 | 213006 | major facilitator superfamily domain containing 4A | -1.59 |
| Tmem132c | 208213 | transmembrane protein 132C | -1.59 |
| Cpm | 70574 | carboxypeptidase M | -1.59 |
| Tulp1 | 22157 | tubby like protein 1 | -1.59 |
| Ppp1r3c | 53412 | protein phosphatase 1, regulatory (inhibitor) subunit 3C | -1.60 |
| Tnfsf9 | 21950 | tumor necrosis factor (ligand) superfamily, member 9 | -1.61 |
| Aoc1 | 76507 | amine oxidase, copper-containing 1 | -1.61 |
| Ccdc42 | 276920 | coiled-coil domain containing 42 | -1.64 |
| Nxph3 | 104079 | neurexophilin 3 | -1.64 |
| Unc80 | 329178 | unc-80, NALCN activator | -1.65 |
| Scn3a | 20269 | sodium channel, voltage-gated, type III, alpha | -1.65 |
| Klk14 | 317653 | kallikrein related-peptidase 14 | -1.66 |
| Mcidas | 622408 | multiciliate differentiation and DNA synthesis associated cell cycle protein | -1.66 |
| Mmp9 | 17395 | matrix metallopeptidase 9 | -1.67 |
| Olfr1342 | 258708 | olfactory receptor 1342 | -1.67 |
| Camkk1 | 55984 | calcium/calmodulin-dependent protein kinase kinase 1, alpha | -1.67 |
| Gmnc | 239789 | geminin coiled-coil domain containing | -1.67 |
| S100a8 | 20201 | S100 calcium binding protein A8 (calgranulin A) | -1.69 |
| Ppp1r1b | 19049 | protein phosphatase 1, regulatory (inhibitor) subunit 1B | -1.71 |
| Pbld1 | 68371 | phenazine biosynthesis-like protein domain containing 1 | -1.72 |
| Slc26a4 | 23985 | solute carrier family 26, member 4 | -1.73 |
| Rasd2 | 75141 | RASD family, member 2 | -1.75 |
Fig 2Heatmap showing changes in global gene expression.
The overall expression patterns across all three treatments groups were visualized for the 3,852 genes with OH vs. FG FDR p-value < 0.05 using a heatmap. Each row represents one gene and each column is one individual mouse, grouped by treatment. The color scale represents standard deviations from the mean expression level across all samples with greater expression represented in red and lesser expression by blue relative to the mean.
Fig 3Significant over-represented KEGG pathways amongst overhaul treated samples.
Over-representation testing completed based on purple and black gene set clusters, as well as both clusters combined, identified from heatmap (Fig 2) using Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways. Twenty-two pathways had more significant genes than expected by chance in at least one of the three comparisons (raw p-value < 0.005). The color of the box represents the –log10(p-value) to give more significant values darker color while the actual p-values are printed inside each box; the grey box indicates no genes in the black cluster mapped to that pathway.